MedPath

Study to investigate the use of REAL INTELLIGENCE™ CORI™ in Knee Replacement Surgeries

Not Applicable
Completed
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2021/07/035056
Lead Sponsor
Smith and Nephew Inc
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
7
Inclusion Criteria

The subject’s treating clinician has decided that REAL INTELLIGENCE™ CORI™ and a compatible Smith+Nephew Knee Implant System is the best treatment for the subject’s unicondylar knee arthroplasty (UKA) or total knee arthroplasty (TKA) and the subject has agreed to the treatment.

- Subject requires a cemented UKA or TKA as a primary indication that meets either criterion A or B.

A. Subject requires a cemented UKA as a primary indication due to any of the following conditions:

1. Non-inflammatory degenerative joint disease, including osteoarthritis

2. Avascular necrosis

3. Requires correction of functional deformity

4. Requires treatment of fractures that were unmanageable using other techniques

B. Subject requires a cemented TKA as a primary indication due to any of the following condition:

1. Degenerative joint disease, including osteoarthritis

2. Rheumatoid arthritis

3. Avascular necrosis

4. Requires correction of functional deformity

5. Requires treatment of fractures that were unmanageable using other techniques

- Subject is of legal age to consent and considered skeletally mature (= 18 years of age at the time of surgery)

- Subject agrees to consent to and to follow the study visit schedule (as defined in the study protocol and informed consent form), by signing the Ethical Committee (EC) or Institutional Review Board (IRB) approved informed consent form.

- Subject plans to be available through one (1) year postoperative follow-up.

- Routine radiographic assessment is possible.

- Subject able to follow instructions and deemed capable of completing all study questionnaires

Exclusion Criteria

Subject receives a CORI Robotics UKA or TKA on the index joint as a revision for a previously failed surgery, or need for complex implants, or any other implant than a standard UKA or TKA (e.g. stems, augments, or custom

made devices).

- Subject has been diagnosed with post-traumatic arthritis

- Subject receives bilateral UKA or TKA

- Subject does not understand the language used in the Informed Consent Form.

- Subject does not meet the indication or is contraindicated for UKA or TKA according to specific Smith+Nephew knee system’s Instructions For Use (IFU).

- Subject has active infection or sepsis (treated or untreated).

- Subject is morbidly obese with a body mass index (BMI) greater than 40.

- Subject is pregnant or breast feeding at the time of surgery.

- Subject, in the opinion of the Investigator, has advanced osteoarthritis or joint disease at the time of surgery and was better suited for an alternate procedure.

- Subject has a condition(s) that may interfere with the TKA or UKA survival or outcome (i.e., Paget’s or Charcot’s disease, vascular insufficiency, muscular atrophy, uncontrolled diabetes, moderate to severe renal

insufficiency or neuromuscular disease, or an active, local infection).

- Subject in the opinion of the Investigator, has an emotional or neurological condition that would pre-empt

their ability or willingness to participate in the study including mental illness, mental retardation, drug or

alcohol abuse.

- Subject, in the opinion of the Investigator, has a neuromuscular disorder that prohibited control of the

index joint.

- Subject is a prisoner or meets the definition of a Vulnerable Subject per ISO 14155 Section 3.5.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Post-operative leg alignment <br/ ><br>Description: <br/ ><br>Post-operative leg alignment via radiographic assessment. Post-operative leg alignment is achieved when the deviation from the subject specific target does not exceed ±3 degrees.Timepoint: 6 weeks
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath